Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Little is known about the relationship between soluble amyloid β (Aβ) and age. We have measured soluble and insoluble Aβ by enzyme‐linked immunosorbent assay (ELISA) in post‐mortem frontal cortex in normal brains (16–95 years) and AD. Insoluble Aβ increased with age, and was significantly higher in Alzheimer's disease (AD) than age‐matched controls. However, levels of soluble Aβ declined with age and were significantly greater in younger adults than older adults with or without AD. In AD, insoluble : soluble Aβ ratio was much higher than in age‐matched controls. The high levels of soluble Aβ in young adults included oligomeric species of Aβ 1‐42. These observations do not preclude Aβ oligomers as neurotoxic mediators of AD but suggest that if they are, the toxicity may be restricted to certain species (eg, β‐pleated protofibrillar species not detected by our assay) or takes decades to manifest. The dramatically increased insoluble : soluble Aβ in AD points to an altered dynamic equilibrium of Aβ in AD, reflecting both enhanced aggregation and continued overproduction or impaired removal of the soluble peptide in older age, when the concentration of this peptide should be declining.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 5×
“Ab monomers are nontoxic (3), whereas there is increasing evidence demonstrating neurotoxicity of oligomeric species (3, 20, 35, 37).”
BackgroundInfluentialRetractedRETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 1×
“b-secretase activity is needed to produce a soluble amino-terminal fragment of APP (N-APP), which is a ligand for death receptor 6 (DR6); this fragment of APP initiates an active caspase-dependent process of axonal pruning and has been reported to have a key role in sculpting the nervous system during development (29).”
BackgroundRetractedAmyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 2×
“In patients with familial AD or Down’s syndrome, soluble Ab is produced in excess throughout life yet AD-related cognitive changes and neurofibrillary pathology develop only after the appearance of Ab plaques (14, 23).”
BackgroundWhen does age-related cognitive decline begin?
Salthouse, T. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.023 · Cited by 1,848 · cited 1×
“It may be relevant to present findings that cognitive decline in healthy educated adults may start as early as the third or fourth decade (33).”
BackgroundSoluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 1×
“Levels of oligomeric Ab are increased in brain tissue from AD patients (19, 21, 24, 38, 40), and correlate with the degree of cognitive decline (11, 21, 40) and density of neurofibrillary tangles (24).”
BackgroundOpposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., & Wolfson, L. (1988) · Neurology · doi:10.1212/wnl.38.11.1682 · Cited by 586
Research works printed but not linked: 25
- 10.1093/oxfordjournals.aje.a008974 · DOI · Paper page
- 10.1016/S1875-2136(08)71801-1 · DOI · Paper page
- 10.1038/nsmb.1437 · DOI · Paper page
- 10.1038/373523a0 · DOI · Paper page
- 10.1097/00005072-199708000-00010 · DOI · Paper page
- 10.1017/S0033291796004199 · DOI · Paper page
- 10.1126/science.274.5284.99 · DOI · Paper page
- 10.1126/science.1079469 · DOI · Paper page
- 10.3233/JAD-2009-0999 · DOI · Paper page
- 10.1146/annurev.neuro.28.061604.135632 · DOI · Paper page
- Mann DM, 1992, The time course of pathological events concerned with plaque formation in Down's syndrome with particular reference to the involvement of microglial cells, Neurodegeneration, 1, 201
- 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- 10.1212/WNL.39.9.1159 · DOI · Paper page
- 10.1038/nrn1587 · DOI · Paper page
- 10.1091/mbc.E06-04-0283 · DOI · Paper page
- 10.1097/00005072-199804000-00007 · DOI · Paper page
- 10.1074/jbc.M501694200 · DOI · Paper page
- 10.1002/glia.20051 · DOI · Paper page
- 10.1016/j.nbd.2009.07.021 · DOI · Paper page
- 10.1038/nm1782 · DOI · Paper page
- Slomnicki LP, 2008, A putative role of the Amyloid Precursor Protein Intracellular Domain (AICD) in transcription, Acta Neurobiol Exp, 68, 219, 10.55782/ane-2008-1691 · DOI · Paper page
- 10.1113/jphysiol.2005.103754 · DOI · Paper page
- 10.1016/j.jneumeth.2008.09.002 · DOI
- Van Helmond Z, 2009, Oligomeric Aβ in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy, Brain Pathol
- 10.1111/j.1750-3639.2008.00190.x · DOI
Cited by
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citationProliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
Danysz, W., & Parsons, C. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02057.x · Cited by 500
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide
Hashimoto, T., Serrano-Pozo, A., Hori, Y., Adams, K. W., Takeda, S., Banerji, A. O., Mitani, A., Joyner, D., Thyssen, D. H., Bacskai, B. J., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1542-12.2012 · Cited by 294
“…oligomeric A in frontal cortex of young adults is higher than that of elderly people or Alzheimer’ disease patients using ELISA experiments (van Helmond et al., 2010), potentially calling into question a relationship between oligomeric A (as measured by the ELISA) with Alzheimer disease…”
BackgroundKehoe, P. G., Wong, S., AL Mulhim, N., Palmer, L. E., & Miners, J. S. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0217-7 · Cited by 203
Self-citation
Metadata
- Authors
- Van Helmond, Z., Miners, J. S., Kehoe, P. G., & Love, S.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2010-06-07
- Volume
- 20
- Issue
- 4
- Pages
- 787-793
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1776336091
- Cited by
- 40
- References
- 17
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1750-3639.2010.00374.x
- The paper
- Van Helmond, Z., Miners, J. S., Kehoe, P. G., & Love, S. (2010). Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2010.00374.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.